首页> 中文期刊>医学信息 >精密过滤输液器与普通输液器临床报道静脉炎不良事件分析

精密过滤输液器与普通输液器临床报道静脉炎不良事件分析

     

摘要

目的:了解精密过滤输液器与普通输液器的安全性﹐为临床安全使用提供参考。方法对2011~2014年期间一次性精密过滤输液器与普通输液器病例对照临床观察报道安全性数据进行统计分析﹐了解和掌握这两种输液器械在临床使用中发生静脉炎不良事件症状﹑严重程度及发生率。结果两种器械均有静脉炎不良事件发生﹐按严重程度分级比较﹐两种器械无统计学意义(>0.05)。精密过滤输液器的不良事件发生率为11.09﹪﹐普通输液器不良事件发生率为36.18﹪﹐两者比较差异有统计学意义(≤0.05)。结论精密过滤输液器与普通输液器比较能有效减轻输液所致的静脉炎不良事件发生率﹐但不能降低其严重程度﹔两种器械的不良事件的发生率均较高。临床医务人员应加强临床使用的安全性监测和护理﹐以降低不良事件发生率。%Objective To provide a reference for clinical and to know more about the safety of the precision filter infusion device and the general infusion device. Methods Analysis the safety data, special about Phlebitis, of precision filter infusion devices and general infusion devices by the clinical cases control observation reports from 2011~2014.Results Phlebitis is the main AE of two of devices. Phlebitis of AE rate of two devices had statistical significance ( ≤0.05)but severity of Phlebitis of two devices had not statistical significance ( >0.05). Precision filter infusion AE rate was 11.09% while general infusion device AE rate was 36.184%.Conclusion Precision filter infusion device can reduce the Phlebitis of AE rate caused by infusion but severity of Phlebitis can not be reduced. Phlebitis of AE rates of the two kinds of devices were higher. We should strengthen the clinical safety monitoring and care, in order to reduce the AE.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号